Search results
Adaptive Biotechnologies Co. (NASDAQ:ADPT) Stake Decreased by Federated Hermes Inc.
ETF DAILY NEWS· 6 days agoFederated Hermes Inc. lessened its holdings in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT – Free Report) by 12.5% during the fourth quarter, according to the company in its most recent ...
Regeneron misses earnings, revenue expectations By Investing.com
Investing.com· 5 hours agoRegeneron (NASDAQ:REGN) experienced a slight decline in its stock price, falling 1.82% after...
The insect farmers turning to AI to help lower costs
BBC via Yahoo News· 8 hours agoThe founder and boss of a company called Full Circle Biotechnology, he is in charge of 20 million black soldier fly larvae. Based at a small, indoor...
Pulmatrix (NASDAQ:PULM) Receives New Coverage from Analysts at StockNews.com
ETF DAILY NEWS· 11 hours agoEquities research analysts at StockNews.com began coverage on shares of Pulmatrix (NASDAQ:PULM – Get Free Report) in a note issued to investors on Thursday. The brokerage set a “hold” rating ...
Recursion Pharmaceuticals, Inc. (RXRX) is Attracting Investor Attention: Here is What You Should...
Zacks via Yahoo Finance· 3 hours agoZacks.com users have recently been watching Recursion Pharmaceuticals (RXRX) quite a bit. Thus, it...
Is Puma Biotechnology, Inc. (NASDAQ:PBYI) A High Quality Stock To Own?
Simply Wall St. via Yahoo Finance· 3 days agoThis article is for those who would like to learn about Return On Equity (ROE). By way of...
Monica A. Kolinsky, Ph.D.
The National Law Review· 9 hours agoMonica is an Associate in the Corporate Department and a member of the Life Sciences Practice Group, and is based in the firm’s Stamford office. Before joining the firm, Monica was of counsel ...
Aurinia Pharmaceuticals (AUPH) Reports Q1 Loss, Tops Revenue Estimates
Zacks· 11 hours agoFree Report) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.17. This quarterly report represents an earnings surprise of 82.35%. A quarter ...
Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More
Zacks via Yahoo Finance· 2 hours agoUnder the terms of the agreement, Repertoire will receive tiered royalties, an upfront payment of...
Novartis to pay up to $1.75 billion for U.S. cancer-focused biotech
Market Watch· 4 hours agoNovartis said it’s paying $1 billion upfront and up to $750 million more in milestone payments for...
